Search all trials

Find therapies in clinical trials near you – page 137

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Neoplasm

Recruiting

Registered drugNo placebo

Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:ALE.P02

Contact Research Centre

Colitis ulcerative+1

Recruiting

Registered drugNo placebo

Study on Vedolizumab and Ustekinumab for Patients with Crohn's Disease and Ulcerative Colitis

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Ustekinumab

Contact Research Centre

T-cell type acute leukaemia+1

Recruiting

InvestigationalNo placebo

Long-term Follow-up Study for Patients with Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Treated with OC-1 Cells

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A

Contact Research Centre

Acute myeloid leukaemia refractory+1

Recruiting

Registered drugNo placebo

Study on the Safety of Eganelisib Alone and with Cytarabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Acute myeloid leukaemia+2

Recruiting

Registered drugNo placebo

Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ivosidenib

Contact Research Centre

Peripheral arterial occlusive disease

Recruiting

Investigational

Study on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:ALLOGENEIC REGULATORY MACROPHAGES

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use

Registered drugNo placebo

France

Participants:18–64 years
Substances:Bevacizumab

Contact Research Centre

Breast cancer

Recruiting

Registered drug

Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Inavolisib

Contact Research Centre

Cholecystitis acute

Recruiting

Registered drugNo placebo

Study on Preoperative Antibiotics for Patients with Acute Cholecystitis: Comparing Ertapenem, Ciprofloxacin, and Cefuroxime

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Cefuroxime

Contact Research Centre

Chronic kidney disease

Recruiting

Registered drugNo placebo

Study on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Finerenone

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drugNo placebo

Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Oesophageal squamous cell carcinoma

Recruiting

Registered drugNo placebo

Study of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Find therapies in clinical trials near you – page 137

10 246 trials match your criteria

Neoplasm

Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

Colitis ulcerative+1

Study on Vedolizumab and Ustekinumab for Patients with Crohn's Disease and Ulcerative Colitis

T-cell type acute leukaemia+1

Long-term Follow-up Study for Patients with Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Treated with OC-1 Cells

Acute myeloid leukaemia refractory+1

Study on the Safety of Eganelisib Alone and with Cytarabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes

Acute myeloid leukaemia+2

Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

Peripheral arterial occlusive disease

Study on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease

Non-small cell lung cancer

Study on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use

Breast cancer

Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Cholecystitis acute

Study on Preoperative Antibiotics for Patients with Acute Cholecystitis: Comparing Ertapenem, Ciprofloxacin, and Cefuroxime

Chronic kidney disease

Study on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients

Plasma cell myeloma refractory

Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

Oesophageal squamous cell carcinoma

Study of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.